Yasushi Saito Selected Research

Idiopathic Hypersomnolence

03/2002

CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.

Articles by Research Topic

Disease

11	Hypercholesterolemia 08/2008 - 06/2002
5	Werner Syndrome (Werner's Syndrome) 01/2008 - 09/2004
3	Insulin Resistance 01/2008 - 09/2004
3	Hyperlipidemias (Hyperlipidemia) 01/2003 - 01/2002
2	Hypertriglyceridemia 06/2008 - 10/2007
2	Atherosclerosis (Atheroma) 11/2007 - 02/2005
2	Type 2 Diabetes Mellitus (MODY) 04/2007 - 04/2007
2	Ulcerative Colitis 11/2006 - 04/2004
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2003 - 12/2002
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2003 - 04/2002
2	Coronary Disease (Coronary Heart Disease) 12/2002 - 02/2002
2	Inflammation 11/2002 - 01/2002
2	Stomach Neoplasms (Stomach Cancer) 11/2002 - 11/2002
1	Autoimmune Hepatitis 08/2008
1	POEMS Syndrome (Syndrome, POEMS) 08/2008
1	Stroke (Strokes) 07/2008
1	Anoxia (Hypoxia) 04/2008
1	Breast Neoplasms (Breast Cancer) 11/2007
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2007
1	Myocarditis (Carditis) 01/2007
1	Obesity 04/2005
1	Weight Loss (Weight Reduction) 09/2004
1	Enteritis 04/2004
1	Cushing Syndrome 02/2004
1	Hyperplasia 02/2004
1	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 01/2004
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2003
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2003
1	Leukemia 12/2003
1	Hypercalcemia (Milk Alkali Syndrome) 12/2003
1	Glomerulonephritis 02/2003
1	Body Weight (Weight, Body) 01/2003
1	Hepatitis 12/2002
1	Thrombosis (Thrombus) 11/2002
1	Ulcer 11/2002
1	Syndrome 06/2002
1	Idiopathic Hypersomnolence 03/2002
1	Narcolepsy 03/2002
1	Cataplexy 03/2002
1	Carotid Artery Diseases 02/2002
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 02/2002

Drug/Important Bio-Agent (IBA)

6	Simvastatin (Zocor)FDA LinkGeneric 08/2008 - 12/2002
4	pioglitazone (Actos)FDA Link 01/2008 - 09/2004
4	NK 104 (pitavastatin)IBA 01/2003 - 01/2002
3	CholesterolIBA 08/2008 - 12/2002
3	Glucose (Dextrose)FDA LinkGeneric 04/2005 - 09/2004
2	HDL CholesterolIBA 06/2008 - 01/2003
2	rosuvastatin (Crestor)FDA Link 10/2007 - 01/2003
2	Malondialdehyde (Propanedial)IBA 01/2004 - 04/2002
2	Pravastatin (Pravachol)FDA LinkGeneric 01/2003 - 06/2002
2	orexins (orexin)IBA 06/2002 - 03/2002
1	AutoantibodiesIBA 08/2008
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 08/2008
1	Immunoglobulins (Immunoglobulin)IBA 08/2008
1	Eicosapentaenoic AcidIBA 07/2008
1	Retinaldehyde (Retinal)IBA 04/2008
1	Aquaporin 1IBA 04/2008
1	Interleukin-6 (Interleukin 6)IBA 01/2008
1	Advanced Glycosylation End ProductsIBA 11/2007
1	Protein Tyrosine PhosphatasesIBA 11/2007
1	risedronic acid (risedronate)FDA LinkGeneric 11/2007
1	Triglycerides (Triacylglycerol)IBA 10/2007
1	Carbon MonoxideIBA 03/2007
1	AdiponectinIBA 01/2007
1	Etidronic Acid (HEDP)FDA LinkGeneric 11/2005
1	apo B48 receptorIBA 01/2005
1	Insulin (Novolin)FDA Link 09/2004
1	ManganeseIBA 04/2004
1	RubidiumIBA 04/2004
1	ZincIBA 04/2004
1	Vasopressins (Vasopressin)IBA 02/2004
1	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2004
1	low density lipoprotein inhibitorIBA 01/2004
1	Lipase (Acid Lipase)IBA 01/2004
1	inter-alpha-inhibitorIBA 01/2004
1	maxacalcitolIBA 12/2003
1	Vitamin D FDA LinkGeneric 12/2003
1	Fc Receptors (Fc Receptor)IBA 02/2003
1	G-substrate (protein G)IBA 01/2003
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 12/2002
1	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 11/2002
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2002
1	DNA (Deoxyribonucleic Acid)IBA 11/2002
1	Interleukin-8 (Interleukin 8)IBA 11/2002
1	geranylgeranylacetone (teprenone)IBA 11/2002
1	Lipoproteins (Lipoprotein)IBA 02/2002
1	Messenger RNA (mRNA)IBA 01/2002
1	OxidoreductasesIBA 01/2002
1	Coenzyme A (CoA)IBA 01/2002

Therapy/Procedure

2	Blood Component Removal (Apheresis) 11/2006 - 04/2004
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2007
1	Stem Cell Transplantation 12/2003
1	Transplants (Transplant) 12/2003